Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

CELLINK

Biotech & Life Sciences · Göteborgs Stad, Sweden · Founded 2016 · IPO 2016 Unicorn

The world’s leading bioconvergence company

Valuation
$177M
Market cap · May/2026
Revenue
$181M
Latest reported FY
EBITDA
$13M
Latest reported FY

Investors

1 investor on CELLINK's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Bosch Ventures

Global footprint

Where CELLINK has talent and traffic

Workforce by country
10 countries with
team presence
🇸🇪 Sweden67.7%
🇺🇸 United States19.6%
🇸🇬 Singapore3.7%
🇮🇳 India2.6%
🇪🇸 Spain2.1%
Top 5 of 10 shown
Web traffic by country
48K monthly visits
across markets
🇺🇸 United States13.8%
🇨🇦 Canada8.3%
🏳️ Korea7.3%
🏳️ Republic of7.1%
🇦🇺 Australia7.1%
Top 5 markets shown

Patent intelligence

$31M patent portfolio · 51 active families

Estimated portfolio value
$31M
17.7% of market cap · 2346.8× the top peer Prenetics ($13k)
51 active patent families
Where CELLINK innovates Mechanical engineeringStructural engineeringBattery cellPhysicsComputer printing

Where CELLINK concentrates vs peers

Each axis is a top-10 topic across CELLINK and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

CELLINK's 8 investments and acquisitions.

Every disclosed deal where CELLINK appeared as a backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across CELLINK's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where CELLINK deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        CELLINK's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        What the market is saying about CELLINK

        An AI-synthesized read of the highest-engagement posts about CELLINK on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See CELLINK on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.